Evidence map›Paper›PMID 24614117›Full record

ArticlePloS one2014

Association of autoimmune Addison's disease with alleles of STAT4 and GATA3 in European cohorts.

Anna L Mitchell, Katie D R Macarthur, Earn H Gan, Lucy E Baggott, Anette S B Wolff, Beate Skinningsrud, Hazel Platt, Andrea Short, Anna Lobell, Olle Kämpe and 26 more

Erratum issuedOpen access · goldAbstract read
In one paragraph

Article in PloS one, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 13 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed, 1 pooled it
3.6field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 1 synthesis or guideline pooled it, 30 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Review
  4. Review
  5. Article
  6. Central-European journal of immunology · 2020
    Article
  7. Epidemiology, pathogenesis, and diagnosis of Addison's disease in adults.Journal of endocrinological investigation · 2019
    Review
  8. Article
  9. Article
  10. Impact of Month of Birth on the Risk of Development of Autoimmune Addison's Disease.The Journal of clinical endocrinology and metabolism · 2016
    Article
  11. Article
  12. Article
  13. Article
4 · The record

Corrections and comments

  • Erratum issued
5 · Who and what money

Authors and funding

36 authors at 17 institutions in 7 countries.

Anna L MitchellInstitute of Genetic Medicine, Newcastle University, Newcastle, United Kingdom.
Katie D R MacarthurInstitute of Genetic Medicine, Newcastle University, Newcastle, United Kingdom.
Earn H GanInstitute of Genetic Medicine, Newcastle University, Newcastle, United Kingdom.
Lucy E BaggottInstitute of Genetic Medicine, Newcastle University, Newcastle, United Kingdom.
Anette S B WolffDepartment of Clinical Science, University of Bergen, Bergen, Norway.
Beate SkinningsrudDepartment of Medical Genetics, Oslo University Hospital, Oslo, Norway; University of Oslo, Oslo, Norway.
Hazel PlattCIGMR, Institute of Population Health, University of Manchester, Manchester, United Kingdom.
Andrea ShortCIGMR, Institute of Population Health, University of Manchester, Manchester, United Kingdom.
Anna LobellUppsala University, Uppsala, Sweden.
Olle KämpeUppsala University, Uppsala, Sweden.
Sophie BensingUppsala University, Uppsala, Sweden; Karolinska Institutet, Stockholm, Sweden.
Corrado BetterleDepartment of Medicine, University of Padua School of Medicine, Padua, Italy.
Anna Kasperlik-ZaluskaDepartment of Endocrinology, Center for Postgraduate Medical Education, Warsaw, Poland.
Magdalena ZurawekInstitute of Human Genetics, Polish Academy of Sciences, Poznan, Poland.
Marta FichnaInstitute of Human Genetics, Polish Academy of Sciences, Poznan, Poland.
Ingrid KockumNeuroimmunology Unit, Department of Clinical Neuroscience and Centrum for Molecular Medicine, Karolinska Institutet, Stockholm, Sweden.
Gabriel Nordling ErikssonDepartment of Molecular Medicine and Surgery, Karolinska Institutet, Stockholm, Sweden.
Olov EkwallThe Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.
Jeanette WahlbergDepartment of Medical and Health Sciences, Division of Endocrinology, Faculty of Health Sciences, Linköping University, Linköping, Sweden.
Per DahlqvistDepartment of Public Health and Clinical Medicine, Umeå University, Umeå, Sweden.
Anna-Lena HultingKarolinska Institutet, Stockholm, Sweden.
Marissa Penna-MartinezDepartment Medicine (Division Endocrinology), University Hospital Frankfurt, Goethe-University, Frankfurt, Germany.
Gesine MeyerDepartment Medicine (Division Endocrinology), University Hospital Frankfurt, Goethe-University, Frankfurt, Germany.
Heinrich KahlesDepartment Medicine (Division Endocrinology), University Hospital Frankfurt, Goethe-University, Frankfurt, Germany.
Klaus BadenhoopDepartment Medicine (Division Endocrinology), University Hospital Frankfurt, Goethe-University, Frankfurt, Germany.
Stephanie HahnerUniversity Hospital Wuerzburg (Department of Medicine, Endocrinology and Diabetology), Wuerzburg, Germany.
Marcus QuinklerClinical Endocrinology, Charité Campus Mitte, Charité University Medicine Berlin, Berlin, Germany.
Alberto FalorniDepartment of Internal Medicine, University of Perugia, Perugia, Italy.
Amanda Phipps-GreenDepartment of Biochemistry, University of Otago, Otago, New Zealand.
Tony R MerrimanDepartment of Biochemistry, University of Otago, Otago, New Zealand.
William OllierCIGMR, Institute of Population Health, University of Manchester, Manchester, United Kingdom.
Heather J CordellInstitute of Genetic Medicine, Newcastle University, Newcastle, United Kingdom.
Dag UndlienDepartment of Medical Genetics, Oslo University Hospital, Oslo, Norway; University of Oslo, Oslo, Norway.
Barbara CzarnockaDepartment of Biochemistry and Molecular Biology, Center for Postgraduate Medical Education, Warsaw, Poland.
Eystein HusebyeDepartment of Clinical Science, University of Bergen, Bergen, Norway; Department of Medicine, Haukeland University Hospital, Bergen, Norway.
Simon H S PearceInstitute of Genetic Medicine, Newcastle University, Newcastle, United Kingdom.
Newcastle University · GBKarolinska Institutet · SEUniversity Hospital Frankfurt · DEUniversity of Manchester · GBInstitute of Human Genetics · PLPostgraduate School of Molecular Medicine · PLUniversity of Bergen · NOUniversity of Oslo · NOUniversity of Otago · NZUppsala University · SECharité - Universitätsmedizin Berlin · DELinköping University · SEUmeå University · SEUniversitätsklinikum Würzburg · DEUniversity of Gothenburg · SEUniversity of Padua · ITUniversity of Perugia · IT

Funding

Medical Research Council G0100594Medical Research Council G0600237Medical Research Council G0900390Medical Research Council G0900753Medical Research Council G0901461Medical Research Council MR/K002279/1
6 · The paper itself

Abstract

backgroundGene variants known to contribute to Autoimmune Addison's disease (AAD) susceptibility include those at the MHC, MICA, CIITA, CTLA4, PTPN22, CYP27B1, NLRP-1 and CD274 loci. The majority of the genetic component to disease susceptibility has yet to be accounted for.

aimTo investigate the role of 19 candidate genes in AAD susceptibility in six European case-control cohorts.

methodsA sequential association study design was employed with genotyping using Sequenom iPlex technology. In phase one, 85 SNPs in 19 genes were genotyped in UK and Norwegian AAD cohorts (691 AAD, 715 controls). In phase two, 21 SNPs in 11 genes were genotyped in German, Swedish, Italian and Polish cohorts (1264 AAD, 1221 controls). In phase three, to explore association of GATA3 polymorphisms with AAD and to determine if this association extended to other autoimmune conditions, 15 SNPs in GATA3 were studied in UK and Norwegian AAD cohorts, 1195 type 1 diabetes patients from Norway, 650 rheumatoid arthritis patients from New Zealand and in 283 UK Graves' disease patients. Meta-analysis was used to compare genotype frequencies between the participating centres, allowing for heterogeneity.

resultsWe report significant association with alleles of two STAT4 markers in AAD cohorts (rs4274624: P = 0.00016; rs10931481: P = 0.0007). In addition, nominal association of AAD with alleles at GATA3 was found in 3 patient cohorts and supported by meta-analysis. Association of AAD with CYP27B1 alleles was also confirmed, which replicates previous published data. Finally, nominal association was found at SNPs in both the NF-κB1 and IL23A genes in the UK and Italian cohorts respectively.

conclusionsVariants in the STAT4 gene, previously associated with other autoimmune conditions, confer susceptibility to AAD. Additionally, we report association of GATA3 variants with AAD: this adds to the recent report of association of GATA3 variants with rheumatoid arthritis.

Indexed as

AllelesGenetic Association StudiesGenetic Predisposition to DiseaseAddison DiseaseAdolescentAdultAgedAged, 80 and overAutoimmune DiseasesCase-Control StudiesChildChild, PreschoolCohort StudiesFemaleGATA3 Transcription FactorGenetic HeterogeneityGATA3 protein, humanGATA3 Transcription FactorSTAT4 protein, humanSTAT4 Transcription Factor

Identifiers

PMID24614117
PMCPMC3948621
OpenAlexW2119138966

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.